FTCD, highly expresses in the liver, serves as a liver-specific autoantigen in patients with autoimmune hepatitis [20] and a candidate tumor suppressor gene in hepatocellular carcinoma [21,22]. This evidence concerns the gene FTCD and hepatocellular carcinoma.